According to FutureWise analysis the market for breast biopsy devices in 2023 is US$ 1.05 billion, and is expected to reach US$ 1.51 billion by 2031 at a CAGR of 4.70%.
Biopsy is a surgical operation that involves removing tissue from an organ. The method is used to determine whether or not a disease, such as inflammatory or malignant diseases, exists. Breast biopsy devices are becoming more popular as chronic diseases become more common. In the breast biopsy devices market, the introduction of the liquid biopsy technique for evaluating breast cancer is trending. Liquid biopsy, or the examination of circulating tumor deoxyribonucleic acid (ctDNA), is a non-invasive and low-risk procedure for studying cancer's genetic profile, tracking patients' therapy responses over time, and detecting malignant tumors. As cancer cells multiply and die, DNA is released, and part of it enters the circulatory system, making cancer easier to identify. Because this technology is effective in detecting early-stage cancer, it is being used in diagnosis by a variety of medical facilities.
Breast cancer is the most frequent cancer among women globally, and it is caused by uncontrolled cell proliferation, which generally results in a lump. According to the National Cancer Institute (NCI), more than 3 million women in the United States were diagnosed with breast cancer in 2014. Furthermore, according to the World Cancer Research Fund International, Belgium had the highest rate of breast cancer in 2012. (WCRF). Furthermore, emerging and underdeveloped nations were diagnosed with a higher number of cases, accounting for nearly 53% of all cases worldwide. These figures show the increasing global prevalence of breast cancer, which is the most important factor driving the market for breast biopsy devices.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Breast Biopsy Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Breast Biopsy Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.